Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species

Chang-xing Qi , Qun Zhou , Zhou Yuan , Zeng-wei Luo , Chong Dai , Hu-cheng Zhu , Chun-mei Chen , Yong-bo Xue , Jian-ping Wang , Ya-fen Wang , Ya-ping Liu , Ming Xiang , Wei-guang Sun , Jin-wen Zhang , Yong-hui Zhang

Current Medical Science ›› 2018, Vol. 38 ›› Issue (1) : 11 -18.

PDF
Current Medical Science ›› 2018, Vol. 38 ›› Issue (1) : 11 -18. DOI: 10.1007/s11596-018-1841-1
Article

Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species

Author information +
History +
PDF

Abstract

Kinsenoside is a main active component isolated from plants of the genus Anoectochilus, and exhibits many biological activities and pharmacological effects, including hepatoprotective, anti-hyperglycemic, anti-hyperliposis, anti-inflammatory, vascular protective and anti-osteoporosis effects and so on, which is contributing to its promising potency in disease treatments. This review aims to recapitulate the pharmacological functions of kinsenoside, as well as its source, extraction, identification, quantitative analysis, pharmacokinetics, synthesis and patent information. The data reported in this work can confirm the therapeutic potential of kinsenoside and provide useful information for further new drug development.

Keywords

Anoectochilus roxburghii / kinsenoside / bioactivity / synthesis / review

Cite this article

Download citation ▾
Chang-xing Qi, Qun Zhou, Zhou Yuan, Zeng-wei Luo, Chong Dai, Hu-cheng Zhu, Chun-mei Chen, Yong-bo Xue, Jian-ping Wang, Ya-fen Wang, Ya-ping Liu, Ming Xiang, Wei-guang Sun, Jin-wen Zhang, Yong-hui Zhang. Kinsenoside: A Promising Bioactive Compound from Anoectochilus Species. Current Medical Science, 2018, 38(1): 11-18 DOI:10.1007/s11596-018-1841-1

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

PLoS One, 2014, 9(2

[2]

BudluangP, PitchakarnP, TingP, et al. . Anti-inflammatory and anti-insulin resistance activities of aqueous extract from Anoectochilus burmannicus. Food Sci Nutr, 2017, 53): 486-496 PMID: 28572933

[3]

DuXM, ToyokichiY, YukihiroS. Butanoic acid glucoside composition of whole body and in vitro plantlets of Anoectochilus formosanus. Phytochemistry, 1998, 49(7): 1925-1928

[4]

ItoA, KasaiR, YamasakiK, et al. . Aliphatic and aromatic glucosides from Anoectochilus koshunensis. Phytochemistry, 1993, 33(5): 1133-1137

[5]

WangJ, WangH, ZhangA, et al. . Recent advances in kinsenoside. Chin Hosp Pharm, 2015, 35(19): 1795-1798

[6]

Jiangsu New Medical College. Dictionary of the Traditional Chinese Medicines, Shanghai: Shanghai Scientific Technologic Publishing House, 1986:2283–2286.

[7]

ShihCC, WuYW, LinWC. Aqueous extract of Anoectochilus formosanus attenuate hepatic fibrosis induced by carbon tetrachloride in rats. Phytomedicine, 2005, 12(6-7): 453-460 PMID: 16008122

[8]

DuXM, SunNY, HayashiJ. Hepatoprotective and antihyperliposis activities of in vitro cammed Anoectochilus formosanus. Phytother Res, 2003, 17(1): 30-33 PMID: 12557243

[9]

ChenZ, HuangZQ. Studies on the hypoglycemic effect of the aqueous extractive of Anoectochilus roxburghii. Pharmacol Clin Chin Mater Med, 2000, 16: 23-24

[10]

TangJ, DengYR, ZhuoYR, et al. . Advances in pharmacological activity of Anoectochilus roxburghii. Strait Pharm J, 2008, 20: 77-79

[11]

TsengCC, ShangHF, WangLF, et al. . Antitumor and immunostimulating effects of Anoectochilus formosanus Hayata. Phytomedicine Int J Phytother Phytopharm, 2006, 13: 366-370

[12]

LiuQ, AiMQ, LiTY, et al. . Protection of kinsenoside against AGEs-induced endothelial dysfunction in human umbilical vein endothelial cells. Life Sei, 2016, 162: 102-107

[13]

HsiaoHB, WuJB, LinH, et al. . Kinsenoside isolated from Anoectochilus Formosanus suppresses LPS-stimulated inflammatory reactions in macrophages and endotoxin shock in mice. Shock, 2011, 35(2): 184-190 PMID: 20661184

[14]

ChengKT, WangYS, ChouHC, et al. . Kinsenoside-mediated lipolysis through an AMPK-dependent pathway in C3H10T1/2 adipocytes Roles of AMPK and PPARa in the lipolytic effect of kinsenoside. Phytomedicine, 2015, 22: 641-647 PMID: 26055129

[15]

MeiY, LuH, HeL, et al. . Kinsenoside and polysaccharide production by rhizome culture of Anoectochilus roxburghii in continuous immersion bioreactor systems. Plant Cell Tiss Organ Cult, 2017, 131: 527-535

[16]

ZhangY, CaiJ, RuanH, et al. . Antihyperglycemic activity of kinsenoside, a high yielding constituent from Anoectochilus roxburghii in streptozotocin diabetic rats. J Ethnopharm, 2007, 114: 141-145

[17]

DuX, SunN, TamuraT, et al. . Higher yielding isolation of kinsenoside in Anoectochilus and its antihyperliposis effect. Biol Pharm Bull, 2001, 24(1): 65-69 PMID: 11201248

[18]

DuXM, IrinoN, FurushoN, et al. . Pharmacologically active compounds in the Anoectochilus and Goodyera species. J Nat Med, 2008, 62(2): 132-148 PMID: 18404313

[19]

WuJB, LinWL, HsiehC, et al. . The hepatoprotective activity of kinsenoside from Anoectochilus formosanus. Phytother Res, 2007, 21(1): 58-61 PMID: 17078107

[20]

HsiehWT, TsaiCT, WuJB, et al. . Kinsenoside, a high yielding constituent from Anoectochilus formosanus, inhibits carbon tetrachloride induced Kupffer cells mediated liver damage. J Ethnopharm, 2011, 135(2): 440-449

[21]

XiangM, LiuT, TanW, et al. . Effects of kinsenoside, a potential immunosuppressive drug for autoimmunehepatitis, on DCs-CD8+T cells communication. Hepatology, 2016, 64(6): 2135-2150 PMID: 27639182

[22]

LiuZL, LiuQ, XiaoB, et al. . The vascular protective properties of kinsenoside isolated from Anoectochilus roxburghii under high glucose condition. Fitoterapia, 2013, 86: 163-170 PMID: 23500382

[23]

Cell Death Dis, 2016, 7(9

[24]

HsiaoHB, HsiehCC, WuJB, et al. . Kinsenoside inhibits the inflammatory mediator release in a type-II collagen induced arthritis mouse model by regulating the T cells responses. BMC Complement Altern Med, 2016, 16: 80 PMID: 26916550 PMCID: 4766613

[25]

HsiaoHB, LinH, WuJB, et al. . Kinsenoside prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis by regulating classical NF-KB pathways. Osteoporos Int, 2013, 245): 1663-1676 PMID: 23143538

[26]

HsiehLY, ChanHH, HungHY, et al. . A rapid quantitative 1H NMR analysis of kinsenoside and other bioactive principles from Anoectochilus formosanus. Anal Methods, 2016, 8: 5645

[27]

RehmanS, KimI, ChoiM, et al. . Evaluation of Metabolic Stability of Kinsenoside, an Antidiabetic Candidate, in Rat and Human Liver microsomes. Mass Spectr Lett, 2015, 6(2): 48-51

[28]

RehmanS, KimI, ChoiM, et al. . Development of a hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the determination of kinsenoside, an antihyperlipidemic candidate, in rat plasma and its application to pharmacokinetic studies. J Pharm Bio Analy, 2016, 120: 19-24

[29]

RehmanS, ChoiM, KimI, et al. . in Vitro Assessment of CYP-Mediated Drug Interactions for Kinsenoside, an Antihyperlipidemic Candidate. Molecules, 2016, 21: 800

[30]

SaitoS, HasegawaT, InabaM, et al. . Combination of borane-dimethyl sulfide complex with catalytic sodium tetrahydroborate as a selective reducing agent for a-hydroxy esters. Versatile chiral building block from (s)-(-)-malic acid. Chem Lett, 1984, 13(8): 1389-1392

[31]

KatsuhikoS, NobuyukiS, MasanoriY, et al. . Synthesis of 3-0-3-D-glucopyranosyl-(3R)-hydroxybutanolide (Kinsenoside) and 3-O-P-D-glucopyranosyl-(3S)-hydroxybutanolide (Goodyeroside A). J Carbohyd Chem, 2005, 24(1): 73-84

[32]

ZhangX, LinZY, ChenQY, et al. . The Total Synthesis of goodyerosideA. Chem Bull, 2004, 5: 377-379

[33]

ZhangX, LinZY, HuangHH, et al. . Novel total synthesis of kinsenoside. Hecheng Huaxue (Chinese), 2004, 12(4): 317-318

[34]

ZhangX, HuangHH, ChenQH. A novel total synthesis of kinsenoside and goodyeroside A relying on the efficient reaction of the chiral 2(5H)-furanones. J Asian Nat Prod Res, 2005, 7(5): 711-721 PMID: 16176903

[35]

ZhangY, XiaY, LaiY, et al. . Efficient Synthesis of Kinsenoside and Goodyeroside A by a Chemo-Enzymatic Approach. Molecules, 2014, 19: 16950-16958 PMID: 25340300

[36]

LinW, WuJ, HoH, et al. . Pharmaceutical compositions comprising kinsenoside for hepatoprotection. US Pat Appl Publ, 2008

[37]

LinW, WuJ, HsiaoH, et al. . Method for inhibiting activation of macrophages, inhibiting formation of osteoclasts, inhibiting function of osteoclasts, and/or activating osteoblasts. US Pat Appl Publ, 2009

[38]

ZhengC, WuY, WuJ, et al. . Application of kinsenoside in preparation of anti-fatigue drugs [Machine Translation]. Faming Zhuanli Shenqing (Chinese), 2017

[39]

TangT, QiaoH. Application of kinsenoside in protecting endothelial cells and treating gouty arthritis. Faming Zhuanli Shenqing (Chinese), 2017

[40]

ZhangY. Preparation of kinsenoside derivatives as PTP1B inhibitors. Faming Zhuanli Shenqing (Chinese), 2009

[41]

ZhangY, XiangM. Kinsenoside having good therapeutic effect on autoimmune hepatitis (AIH), and its application and preparation method. Faming Zhuanli Shenqing (Chinese), 2017

[42]

WuT, ChanH, WuC, et al. . Quantitative analysis method and separation method of kinsenoside. Faming Zhuanli Shenqing (Chinese), 2013

[43]

LiuQ, LiuZ. Quantitative analyzing and detecting method for kinsenoside. Faming Zhuanli Shenqing (Chinese), 2014

AI Summary AI Mindmap
PDF

203

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/